Archive: 09/04/2014

Dabrafenib: Also no added benefit over vemurafenib

Dabrafenib (trade name: Tafinlar) has been approved since August 2013 for the treatment of advanced melanoma. In January 2014, in an early benefit assessment pursuant to the "Act on the Reform of the Market for Medicinal ...

Pharma firms turn attention to hearing loss

Hearing loss affects 36 million Americans to some degree, often leaving them feeling isolated, but it has received little attention from the pharmaceutical industry—until now. Small firms have brought a handful of potential ...

Italy scraps ban on donor-assisted reproduction

Italy's Constitutional Court on Wednesday struck down a Catholic Church-backed ban against assisted reproduction with sperm or egg donors that has forced thousands of sterile couples to seek help abroad.

Physical activity is beneficial for late-life cognition

Physical activity in midlife seems to protect from dementia in old age, according to a study carried out at the University of Eastern Finland. Those who engaged in physical activity at least twice a week had a lower risk ...

page 4 from 8